GENERIUM is a full-cycle innovative high-end pharmaceutical company. We are the leader in Russian orphan pharmaceutical market. GENERIUM possesses its own R&D park, which is capable to handle the full cycle of development of any biological drug, from molecule design to commercial production. We are collaborating in science with leading biotechnological companies and institutes from all over the world. GENERIUMs manufacturing facilities are equipped with high-end equipment. The work is organized under GMP standards and our plants are ready to produce any kind of biological drugs or ATMPs. Our mission – our ideas to save life and health.
| Website | http://www.generium.ru |
| Revenue | $6.6 million |
| Employees | 190 (122 on RocketReach) |
| Founded | 2009 |
| Address | 14 Vladimirskaya St, Vol ginskiy, Vladimir 601125, RU |
| Phone | +7 492 437-31-04 |
| Industry | Biotechnology Research, Real Estate |
| Keywords | Orphan Drugs, Pharmaceutical Products, Biologics, Biopharmaceutical Development, Pharmaceutical Research, Biotechnology, Drug Discovery, Drug Manufacturing, Pharmaceutical Innovation, Clinical Trials, Drug Formulation, Generic Drugs, Pharmaceutical Quality, Regulatory Affairs, Healthcare, Health Technology |
| Competitors | Boehringer Ingelheim, Teva Pharmaceuticals, Sandoz, Glenmark Pharmaceuticals, JSC BIOCAD, R-Pharm, Valeant Pharmaceuticals, MSD, AstraZeneca Russia, Sintez Technologies Limited +23 more (view full list) |
| SIC | SIC Code 60 Companies, SIC Code 602 Companies |
| NAICS | NAICS Code 522 Companies, NAICS Code 52211 Companies, NAICS Code 522110 Companies, NAICS Code 5221 Companies, NAICS Code 52 Companies |
Looking for a particular Generium employee's phone or email?
The Generium annual revenue was $6.6 million in 2026.
Dmitry Sokolov is the CIO of Generium.
122 people are employed at Generium.
Generium is based in Vol ginskiy, Vladimir.
The NAICS codes for Generium are [522, 52211, 522110, 5221, 52].
The SIC codes for Generium are [60, 602].